-
1
-
-
0020508556
-
Primary biliary cirrhosis: A model autoimmune disease
-
1. James SP, Hoofnagle JH, Strober W, Jones EA: Primary biliary cirrhosis: A model autoimmune disease. Ann Intern Med 99:500-512, 1983
-
(1983)
Ann Intern Med
, vol.99
, pp. 500-512
-
-
James, S.P.1
Hoofnagle, J.H.2
Strober, W.3
Jones, E.A.4
-
2
-
-
0028775527
-
PBC: Clarifying the issue
-
2. Sherlock S: PBC: Clarifying the issue. Am J Med 94:27-33, 1994
-
(1994)
Am J Med
, vol.94
, pp. 27-33
-
-
Sherlock, S.1
-
3
-
-
0030597246
-
Primary biliary cirrhosis
-
3. Kaplan MM: Primary biliary cirrhosis. N Engl J Med 335:1570-1580, 1996
-
(1996)
N Engl J Med
, vol.335
, pp. 1570-1580
-
-
Kaplan, M.M.1
-
4
-
-
0023894907
-
High incidence of poor sulfoxidation in patients with primary biliary cirrhosis
-
4. Olomu AB, Vickers CR, Waring RH, Clements D, Babbs C, Warnes T, Elias E: High incidence of poor sulfoxidation in patients with primary biliary cirrhosis. N Engl J Med 318:1089-1092, 1988
-
(1988)
N Engl J Med
, vol.318
, pp. 1089-1092
-
-
Olomu, A.B.1
Vickers, C.R.2
Waring, R.H.3
Clements, D.4
Babbs, C.5
Warnes, T.6
Elias, E.7
-
5
-
-
0013967349
-
Biliary cirrhosis induced by chlorpromazine
-
5. Walker CO, Combes B: Biliary cirrhosis induced by chlorpromazine. Gastroenterology 51:631-640, 1966
-
(1966)
Gastroenterology
, vol.51
, pp. 631-640
-
-
Walker, C.O.1
Combes, B.2
-
6
-
-
0028007158
-
Chlorpromazine-induced vanishing bile duel syndrome leading to biliary cirrhosis
-
6. Moradpour D, Altorfer J, Flury R, Greminger P, Mayenberger C, Jost R, Schmid M: Chlorpromazine-induced vanishing bile duel syndrome leading to biliary cirrhosis. Hepatology 20:1437-1441, 1994
-
(1994)
Hepatology
, vol.20
, pp. 1437-1441
-
-
Moradpour, D.1
Altorfer, J.2
Flury, R.3
Greminger, P.4
Mayenberger, C.5
Jost, R.6
Schmid, M.7
-
7
-
-
0015320622
-
Hepatic injury associated with the phenothiazines clinicopathologic and follow-up study of 36 patients
-
7. Izhak KG, Irey NS: Hepatic injury associated with the phenothiazines clinicopathologic and follow-up study of 36 patients. Arch Pathol 93:283-304, 1972
-
(1972)
Arch Pathol
, vol.93
, pp. 283-304
-
-
Izhak, K.G.1
Irey, N.S.2
-
8
-
-
0013693724
-
Xanthomatous biliary cirrhosis following chlorpromazine, with observations indicating overproduction of cholesterol, hyperprothrombinemia and the development of portal hypertension
-
8. Myers JD, Olson RE, Lewis JH, Moran TJ: Xanthomatous biliary cirrhosis following chlorpromazine, with observations indicating overproduction of cholesterol, hyperprothrombinemia and the development of portal hypertension. Trans Assoc Am Physicians 70:243-261, 1957
-
(1957)
Trans Assoc Am Physicians
, vol.70
, pp. 243-261
-
-
Myers, J.D.1
Olson, R.E.2
Lewis, J.H.3
Moran, T.J.4
-
9
-
-
33744587069
-
Chronic chlorpromazine jaundice, with particular reference to its relationship to PBC
-
9. Read AE: Chronic chlorpromazine jaundice, with particular reference to its relationship to PBC. Am J Med 31:249, 1996
-
(1996)
Am J Med
, vol.31
, pp. 249
-
-
Read, A.E.1
-
10
-
-
0014406377
-
Biliary cirrhosis following the administration of methyltestosterone
-
10. Glober GA, Wilkerson JA: Biliary cirrhosis following the administration of methyltestosterone. JAMA 204:169-171, 1968
-
(1968)
JAMA
, vol.204
, pp. 169-171
-
-
Glober, G.A.1
Wilkerson, J.A.2
-
11
-
-
0001077913
-
Chronic cholestasis following prolonged tolbutamide administration associated with destructive cholangitis and cholangiolitis
-
11. Gregory DH, Zaki GF, Sarosi GA, Carey JB: Chronic cholestasis following prolonged tolbutamide administration associated with destructive cholangitis and cholangiolitis. Arch Pathol 84:194-201, 1967
-
(1967)
Arch Pathol
, vol.84
, pp. 194-201
-
-
Gregory, D.H.1
Zaki, G.F.2
Sarosi, G.A.3
Carey, J.B.4
-
12
-
-
0028007370
-
Flucloxacillin-associated hepatic injury
-
12. Koek GH, Sticker BH, Block AP, Schlam SW, Desmet VJ: Flucloxacillin-associated hepatic injury. Liver 14:225, 1994
-
(1994)
Liver
, vol.14
, pp. 225
-
-
Koek, G.H.1
Sticker, B.H.2
Block, A.P.3
Schlam, S.W.4
Desmet, V.J.5
-
13
-
-
0028883895
-
Primary biliary cirrhosis induced by interferonalfa therapy for hepatitis C virus infection
-
13. D'Amico E, Paroli M, Fratelli V, Palazzi C, Barnaba V, Callea F, Consoli G: Primary biliary cirrhosis induced by interferonalfa therapy for hepatitis C virus infection. Dig Dis Sci 40:2113-2116, 1995
-
(1995)
Dig Dis Sci
, vol.40
, pp. 2113-2116
-
-
D'Amico, E.1
Paroli, M.2
Fratelli, V.3
Palazzi, C.4
Barnaba, V.5
Callea, F.6
Consoli, G.7
-
14
-
-
0021987623
-
Erythromycin: A microbial and clinical perspective after 30 years of clinical use
-
14. Washington JA, Wilson WR: Erythromycin: A microbial and clinical perspective after 30 years of clinical use. Mayo Clin Proc 60:271-278, 1985
-
(1985)
Mayo Clin Proc
, vol.60
, pp. 271-278
-
-
Washington, J.A.1
Wilson, W.R.2
-
15
-
-
0028050273
-
Discordant occurence of primary biliary cirrhosis in monozygotic twins
-
15. Kaplan MM, Rabson AR, Lee Y-M, Williams DL, Montaperto PA: Discordant occurence of primary biliary cirrhosis in monozygotic twins. N Engl J Med 331:952, 1994
-
(1994)
N Engl J Med
, vol.331
, pp. 952
-
-
Kaplan, M.M.1
Rabson, A.R.2
Lee, Y.-M.3
Williams, D.L.4
Montaperto, P.A.5
-
16
-
-
0021264366
-
Malignancy in primary biliary cirrhosis. High incidence of breast cancer in affected women
-
16. Wolke AM, Schaffner F, Kapelman B, Sacks HS: Malignancy in primary biliary cirrhosis. High incidence of breast cancer in affected women. Am J Med 76:1075-1078, 1984
-
(1984)
Am J Med
, vol.76
, pp. 1075-1078
-
-
Wolke, A.M.1
Schaffner, F.2
Kapelman, B.3
Sacks, H.S.4
-
17
-
-
0012453837
-
Natural history of early primary biliary cirrhosis
-
17. Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OF: Natural history of early primary biliary cirrhosis. Lancet 348:1399-1402, 1996
-
(1996)
Lancet
, vol.348
, pp. 1399-1402
-
-
Metcalf, J.V.1
Mitchison, H.C.2
Palmer, J.M.3
Jones, D.E.4
Bassendine, M.F.5
James, O.F.6
|